当前位置:
X-MOL 学术
›
Nat. Mater.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adoptive T cell cancer therapy
Nature Materials ( IF 41.2 ) Pub Date : 2018-05-23 , DOI: 10.1038/s41563-018-0094-5 Karine N. Dzhandzhugazyan , Per Guldberg , Alexei F. Kirkin
Nature Materials ( IF 41.2 ) Pub Date : 2018-05-23 , DOI: 10.1038/s41563-018-0094-5 Karine N. Dzhandzhugazyan , Per Guldberg , Alexei F. Kirkin
Adoptive T cell cancer therapy
中文翻译:
过继性T细胞癌治疗
过继性T细胞癌治疗
更新日期:2018-05-24
Adoptive T cell cancer therapy, Published online: 23 May 2018; doi:10.1038/s41563-018-0094-5
Tumour heterogeneity and off-target toxicity are current challenges of cancer immunotherapy. Karine Dzhandzhugazyan, Per Guldberg and Alexei Kirkin discuss how epigenetic induction of tumour antigens in antigen-presenting cells may form the basis for multi-target therapies.中文翻译:
过继性T细胞癌治疗
过继性T细胞癌治疗
过继性T细胞癌症治疗,在线发布:2018年5月23日; doi:10.1038 / s41563-018-0094-5
肿瘤异质性和脱靶毒性是癌症免疫治疗的当前挑战。Karine Dzhandzhugazyan,Per Guldberg和Alexei Kirkin讨论了抗原呈递细胞中肿瘤抗原的表观遗传诱导如何形成多靶点疗法的基础。